GE HealthCare in talks for $1bn Sofie Biosciences acquisition

GE HealthCare is negotiating to acquire Sofie Biosciences, a maker of cancer scan chemicals, for around $1bn. This would be its second major purchase since splitting from General Electric, signaling continued M&A-driven growth strategy. The deal's completion and terms remain uncertain.